Junpeng Peng

Junpeng Peng, Ph.D., MBA, is the Director of Technical Quality at Biogen, where they leverage extensive experience in pharmaceutical development, quality control, and project management. They previously held key positions at notable organizations, including Eli Lilly and Company, where they contributed significantly to the rapid FDA approval of Alimta and received the 2012 Eli Lilly President's Scientific Recognition Award. With a foundation in analytical development and manufacturing science, Junpeng has managed complex tech transfer projects and led global quality integration initiatives throughout their career. They earned an Executive MBA from Purdue University Krannert School of Management and possess a diverse educational background in pharmaceutical sciences.